I
I. Gaertner
Publications - 3
Citations - 533
I. Gaertner is an academic researcher. The author has contributed to research in topics: Therapeutic drug monitoring & Context (language use). The author has an hindex of 3, co-authored 3 publications receiving 517 citations.
Papers
More filters
Journal ArticleDOI
The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry.
Pierre Baumann,Christoph Hiemke,S. Ulrich,Gabriel Eckermann,I. Gaertner,Manfred Gerlach,Hans-Joachim Kuss,Gerd Laux,B. Müller-Oerlinghausen,M. L. Rao,P. Riederer,Gerald Zernig +11 more
TL;DR: In this article, the authors present a consensus guideline for the use of therapeutic drug monitoring (TDM) in psychopharmakologie and pharmacopsychiatrie in psychiatry.
Journal ArticleDOI
Therapeutic drug monitoring of tricyclic antidepressants: how does it work under clinical conditions?
Matthias J. Müller,A. Dragicevic,M. Fric,I. Gaertner,K Grasmäder,Sebastian Härtter,E. Hermann,Hans-Joachim Kuss,Gerd Laux,W. Oehl,M. L. Rao,N. Rollmann,Harald Weigmann,M. Weber-Labonte,C Hiemke +14 more
TL;DR: Treating depression with TCA can be optimized by early TDM, which is superior to clinical judgment on its own, as measured with changes in the HAMD or CGI response rates from baseline to endpoint.
Journal ArticleDOI
Therapeutic monitoring of psychotropic drugs: an outline of the AGNP-TDM expert group consensus guideline.
Pierre Baumann,Christoph Hiemke,S. Ulrich,I. Gaertner,M. L. Rao,Gabriel Eckermann,Manfred Gerlach,Hans-Joachim Kuss,Gerd Laux,B. Müller-Oerlinghausen,P. Riederer,Gerald Zernig +11 more
TL;DR: A multidisciplinary group comprised of clinical biochemists, clinical pharmacologists, and psychiatrists of the AGNP to provide a consensus guideline to optimize TDM of antidepressants, antipsychotics, and opioid substituents.